|
Ramelteon: A melatonin receptor agonist for the treatment of insomnia
V Devi, PK Shankar
Department of Pharmacology, Melaka Manipal Medical College, Manipal, India
Correspondence Address:
V Devi
Department of Pharmacology, Melaka Manipal Medical College, Manipal
India
Ramelteon is a novel MT1 and MT2 melatonin receptor selective agonist recently approved for the treatment of insomnia characterized by difficulty in sleep onset. It is a nonscheduled drug since it lacks the potential for abuse and does not interact with neurotransmitter receptors most associated with these phenomena. Although the effects of ramelteon use >5 weeks are unknown, the available data confirms its safety and efficacy for short-term use. Clinical use and future research should uncover more information about ramelteon«SQ»s properties.
How to cite this article:
Devi V, Shankar P K. Ramelteon: A melatonin receptor agonist for the treatment of insomnia.J Postgrad Med 2008;54:45-48
|
How to cite this URL:
Devi V, Shankar P K. Ramelteon: A melatonin receptor agonist for the treatment of insomnia. J Postgrad Med [serial online] 2008 [cited 2022 May 21 ];54:45-48
Available from: https://www.jpgmonline.com/article.asp?issn=0022-3859;year=2008;volume=54;issue=1;spage=45;epage=48;aulast=Devi;type=0 |
|
|
|
